A cancer trial scandal and its regulatory backlash

Razelle Kurzrock; Hagop Kantarjian; David J. Stewart

doi:10.1038/nbt.2792

A cancer trial scandal and its regulatory backlash

Razelle Kurzrock, Hagop Kantarjian, David J. Stewart

Leukemia

Research output: Contribution to journal › Comment/debate › peer-review

12 Scopus citations

Original language	English (US)
Pages (from-to)	27-31
Number of pages	5
Journal	Nature biotechnology
Volume	32
Issue number	1
DOIs	https://doi.org/10.1038/nbt.2792
State	Published - Jan 2014

ASJC Scopus subject areas

Biotechnology
Bioengineering
Applied Microbiology and Biotechnology
Molecular Medicine
Biomedical Engineering

Access to Document

10.1038/nbt.2792

Cite this

@article{463e7e37ae8940148094bcb4f6bba34d,

title = "A cancer trial scandal and its regulatory backlash",

author = "Razelle Kurzrock and Hagop Kantarjian and Stewart, {David J.}",

year = "2014",

month = jan,

doi = "10.1038/nbt.2792",

language = "English (US)",

volume = "32",

pages = "27--31",

journal = "Nature biotechnology",

issn = "1087-0156",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - A cancer trial scandal and its regulatory backlash

AU - Kurzrock, Razelle

AU - Kantarjian, Hagop

AU - Stewart, David J.

PY - 2014/1

Y1 - 2014/1

UR - http://www.scopus.com/inward/record.url?scp=84892181395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892181395&partnerID=8YFLogxK

U2 - 10.1038/nbt.2792

DO - 10.1038/nbt.2792

M3 - Comment/debate

C2 - 24406925

AN - SCOPUS:84892181395

SN - 1087-0156

VL - 32

SP - 27

EP - 31

JO - Nature biotechnology

JF - Nature biotechnology

IS - 1

ER -

A cancer trial scandal and its regulatory backlash

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this